ADMA Biologics, Inc. ADMA
13.21 USD +2.73 (+26.05%)
At closeNov 5, 2026, 7:59 PM EST
13.27 +0.06 +0.44%
After hours · Nov 5, 7:59 PM ET
11.90 Day range 13.77
7.21 52-week range 20.46
- YTD
- -27.58%
- 1 year
- -14.05%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 510.17M | 426.45M | 258.21M | 154.08M | 80.94M | |
| 292.76M | 219.55M | 88.94M | 35.27M | 1.17M | |
| 191.44M | 138.98M | 21.63M | -39.37M | -58.37M | |
| 146.93M | 197.67M | -28.24M | -65.90M | -71.65M | |
| 0.60 | 0.81 | -0.13 | -0.33 | -0.51 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 87.63M | 103.15M | 51.35M | 86.52M | 51.09M | |
| 624.24M | 488.68M | 329.18M | 348.46M | 276.25M | |
| 146.92M | 139.66M | 193.98M | 196.49M | 135.08M | |
| 73.24M | 73.56M | 131.64M | 143.74M | 95.46M | |
| 477.32M | 349.02M | 135.21M | 151.97M | 141.17M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 50.40M | 118.67M | 8.80M | -59.51M | -112.37M | |
| -21.89M | -8.57M | -4.98M | -13.91M | -13.51M | |
| -44.02M | -58.30M | -38.99M | 108.85M | 121.05M | |
| -22.57M | -8.23M | -4.77M | -13.91M | -13.51M | |
| -15.52M | 51.80M | -35.17M | 35.43M | -4.83M |